Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ - Fred Hutchinson Cancer Center
Young mother’s Hodgkin lymphoma diagnosis felt ‘devastating’ Fred Hutchinson Cancer Center
Hodgkin Lymphoma News
Cherokee County rallies behind teen with Hodgkin lymphoma - Cherokee Tribune
Cherokee County rallies behind teen with Hodgkin lymphoma Cherokee Tribune
Non-Hodgkin lymphoma survivor thankful for clinical trial - MD Anderson Cancer Center
Non-Hodgkin lymphoma survivor thankful for clinical trial MD Anderson Cancer Center
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma - Nature
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma Nature
Hodgkin lymphoma (Hodgkin disease) - Mayo Clinic
Hodgkin lymphoma (Hodgkin disease) Mayo Clinic
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review - Frontiers
Primary non-Hodgkin lymphoma in the muscle of left lower extremity: a case report and literature review Frontiers
Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma - Targeted Oncology
Durable 3-Year Superiority of N-AVD in Advanced Hodgkin Lymphoma Targeted Oncology
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era - CancerNetwork
Progress in the Treatment of Advanced-Stage Classical Hodgkin Lymphoma in the PET-Adapted Era CancerNetwork
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive Overview - ScienceDirect.com
Breast Cancer Risk After Chest Radiotherapy in Hodgkin Lymphoma Survivors: A Comprehensive Overview ScienceDirect.com
First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making - ASCO Daily News
First-Line Options in Advanced-Stage Classical Hodgkin Lymphoma: Weighing Efficacy, Toxicity, and Quality of Life in Decision-Making ASCO Daily News
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma - NEJM Evidence
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma NEJM Evidence
Learn About How Survival Rates Are Improving With Hodgkin Disease - Verywell Health
Learn About How Survival Rates Are Improving With Hodgkin Disease Verywell Health
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season - ESPN
Miami F Marcus Allen has non-Hodgkin lymphoma, out for season ESPN
Lawyers for US cancer sufferers challenge Bayer’s $7.25bn Roundup settlement deal - The Guardian
Lawyers for US cancer sufferers challenge Bayer’s $7.25bn Roundup settlement deal The Guardian
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - MD Anderson Cancer Center
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy MD Anderson Cancer Center
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature - Frontiers
Low-grade B-cell non-Hodgkin lymphoma in the sternocleidomastoid muscle: a case report and review of literature Frontiers
Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment - Targeted Oncology
Low-Dose Nivolumab Offers Novel Strategy for Hodgkin Lymphoma Treatment Targeted Oncology
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation - Nature
Impact of early failure of induction on transplant outcomes in Hodgkin lymphoma | Bone Marrow Transplantation Nature
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about MD Anderson coming to Austin - MD Anderson Cancer Center
Stage IV non-Hodgkin lymphoma survivor: Why I’m excited about MD Anderson coming to Austin MD Anderson Cancer Center
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma - Targeted Oncology
Axi-Cel Shows Durable Responses, Curative Hope in Non-Hodgkin Lymphoma Targeted Oncology
Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study | Scientific Reports - Nature
Clinical features and outcomes of newly diagnosed classical Hodgkin lymphoma patients in Saudi Arabia: a multicenter cohort study | Scientific Reports Nature
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma - The ASCO Post
Nivolumab Plus AVD Reduces Disease Progression Risk in Adolescents With Advanced Classical Hodgkin Lymphoma The ASCO Post
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma - NEJM Evidence
An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma NEJM Evidence
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree - Cureus
A Rare Case of Non-Hodgkin Lymphoma of the Tracheobronchial Tree Cureus
Classic Hodgkin’s Lymphoma With Epstein–Barr Viremia and Lymphadenopathy - Wiley Online Library
Classic Hodgkin’s Lymphoma With Epstein–Barr Viremia and Lymphadenopathy Wiley Online Library
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients - ASCO Publications
Antibody-Based Therapies for the Treatment of Hodgkin Lymphoma in Older Patients ASCO Publications
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank - Wiley Online Library
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank Wiley Online Library
Sewickley father detained by ICE as 6-year-old daughter begins cancer treatment - WTAE
Sewickley father detained by ICE as 6-year-old daughter begins cancer treatment WTAE
Treatment outcomes of ABVD in classical Hodgkin lymphoma patients from Thailand without procarbazine access - Nature
Treatment outcomes of ABVD in classical Hodgkin lymphoma patients from Thailand without procarbazine access Nature
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma - Cureus
Breast Mass as an Atypical Presentation of Non-Hodgkin Lymphoma Cureus
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials - Nature
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials Nature
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients - Roswell Park Comprehensive Cancer Center
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients Roswell Park Comprehensive Cancer Center
‘Elevated’ Hodgkin’s lymphoma numbers among teens at Medina High School - Cleveland 19 News
‘Elevated’ Hodgkin’s lymphoma numbers among teens at Medina High School Cleveland 19 News
Subgroup analysis of treatment pathways and clinical outcomes in Hodgkin lymphoma in Latin America from the retrospective B-HOLISTIC study - Nature
Subgroup analysis of treatment pathways and clinical outcomes in Hodgkin lymphoma in Latin America from the retrospective B-HOLISTIC study Nature
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 - The ASCO Post
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 The ASCO Post
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States - Nature
Population based analysis of twenty year incidence trends of pediatric Hodgkin lymphoma in the United States Nature
Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective - Cureus
Procalcitonin as a Potential Prognostic Marker in Advanced Hodgkin Lymphoma: A Case-Based Perspective Cureus
New Model Predicts Risk of Progression in Early-Stage Classical Hodgkin Lymphoma - The ASCO Post
New Model Predicts Risk of Progression in Early-Stage Classical Hodgkin Lymphoma The ASCO Post
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review - Frontiers
Sintilimab combined with AVD for the treatment of composite Hodgkin lymphoma and follicular lymphoma: a case report and literature review Frontiers